Most cited papers from John Paul II Hospital

The most cited paper from John Paul II Hospital is "Adjuvant Nivolumab in Resected Esophageal or Gastroesophageal Junction Cancer" (Ronan Joseph Kelly et al., 2021), with 1,872 citations. Next come "COVID-19 and the cardiovascular system: implications for risk assessment, diagnosis, and treatment options" (1,515) and "Ramucirumab plus docetaxel versus placebo plus docetaxel for second-line treatment of stage IV non-small-cell lung cancer after disease progression on platinum-based therapy (REVEL): a multicentre, double-blind, randomised phase 3 trial" (1,321).

Showing 50 of 62 papers. Every paper with more than 98 citations is listed.

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.